Clinical Trials Directory

Trials / Completed

CompletedNCT03899974

Metabolic Effects of High-amylose Wheat-based Breads

Metabolic Effects of High-amylose Wheat-based Breads in Overweight Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The amylose-amylopectin ratio influences starch properties. A higher amylose content is associated with slower starch digestion thus reducing the postprandial plasma glucose response and improving the overall postprandial metabolism. So far, limited evidence is available on the metabolic effect of wheat-based foods rich in amylose. This randomised controlled study investigated the acute metabolic effects of amylose-rich wheat-based breads in overweight subjects focusing on potential mechanisms.

Conditions

Interventions

TypeNameDescription
OTHERTest mealParticipants received in random order the three test meal (700Kcal, 80g available carbohydrates) containing breads prepared with amylose-rich wheat flours (70% or 85%) or conventional flour. Blood samples were collected at fasting and every 30 minutes over 4 hours. Breath hydrogen was evaluated as a marker of intestinal fermentation. Participants underwent Visual Analogue Scale to assess subjective appetite sensations. After 4 hours, all participants consumed a standard lunch (700 kcal, 100 g available carbohydrates) identical on all the three experimental days to evaluate the "second meal effect" from breakfast to lunch.

Timeline

Start date
2018-03-01
Primary completion
2018-12-15
Completion
2019-07-31
First posted
2019-04-02
Last updated
2019-12-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03899974. Inclusion in this directory is not an endorsement.